Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program

RecruitingOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

August 1, 2020

Primary Completion Date

October 12, 2030

Study Completion Date

October 12, 2030

Conditions
Hereditary Transthyretin-mediated (hATTR) AmyloidosisPolyneuropathy
Trial Locations (7)

52242

RECRUITING

Clinical Trial Site, Iowa City

Unknown

RECRUITING

Clinical Trial Site, Nantes

RECRUITING

Clinical Trial Site, Münster

RECRUITING

Clinical Trial Site, Pavia

RECRUITING

Clinical Trial Site, Groningen

RECRUITING

Clinical Trial Site, Lisbon

RECRUITING

Clinical Trial Site, Madrid

Sponsors
All Listed Sponsors
lead

Alnylam Pharmaceuticals

INDUSTRY